Brivudine NEW
| Price | $55 | $72 | $98 |
| Package | 50mg | 100mg | 200mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-20 |
Product Details
| Product Name: Brivudine | CAS No.: 69304-47-8 |
| Purity: 99.51% | Supply Ability: 10g |
| Release date: 2026/04/20 |
Product Introduction
Bioactivity
| Name | Brivudine |
| Description | Brivudine (BVDU), an antiviral medicine, is used in the therapy of herpes zoster. |
| In vitro | Brivudine is an analog of thymidine, and is incorporated into the viral DNA. It blocks the action of DNA polymerases thereby inhibiting viral replication. It has a stronger antiviral effect against the varicella-zoster virus than reference compounds such as aciclovir or penciclovir[1]. It has high, selective activity against varicella zoster virus (VZV), inhibiting VZV replication, possibly through competitive inhibition of viral DNA polymerase, or by acting as an alternative substrate to deoxythymidine triphosphate, causing viral DNA strand breakage[2]. |
| In vivo | At a dose of 125 mg once daily, brivudine has been shown to be superior to aciclovir with respect to reducing the period of new blister production and shortening the duration of post-herpetic neuralgia[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | DMSO : 50 mg/mL (150.09 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (30.02 mM), Sonication is recommended. |
| Keywords | VZV | Inhibitor | inhibit | HSV-1 | Cytomegalovirus | CMV | Brivudine |
| Inhibitors Related | Rifampicin | Phenytoin sodium | Levofloxacin hydrochloride | L-Lysine | L-Lysine hydrochloride | Oxyresveratrol | Ofloxacin | Vidarabine | Acyclovir sodium | Acyclovir | Thymidine | Danthron |
| Related Compound Libraries | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Preclinical Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:294868-24-9
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $55.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-20 | |
|
VIP4Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $55.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
|
VIP4Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2025-04-04 | ||
| $780.00 |
VIP3Y
|
R&D Scientific Inc.
|
2024-04-27 | |
| $200.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2023-06-26 | ||
| $100.00 |
Shijiazhuang Gantuo Biotechnology Co., Ltd
|
2023-04-11 | ||
| $200.00 |
Hebei Best Biological Technology Co., Ltd
|
2022-12-01 | ||
| $1.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY